Bold Vision.
Innovation at its best.

ProPhase Labs is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Our world-class CLIA labs and cutting-edge diagnostic technology provide wellness solutions for healthcare providers and consumers.

We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives.  We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach.







Press Releases

See our latest innovations and breaking news

Jun 07 2023 8:00AM ET

ProPhase Labs to Present at the Diamond Equity Research Emerging Growth Invitational on Tuesday, June 13, 2023

Read More

Jun 01 2023 8:30AM ET

ProPhase Labs’ Cancer Therapeutic, Linebacker-1, pre-clinical studies with Dana Farber/Harvard Cancer Institute demonstrate impressive utility and move into next phase of testing

Read More

May 11 2023 8:00AM ET

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2023

Read More
Investor Relations

Get In Touch

We care about your questions and will be in touch usually within 24 hours

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Dev Tool:

Request: None
Matched Rewrite Rule: None
Matched Rewrite Query: None
Loaded Template: front-page.php